Abstract
Primary liver cancer (PLC) is the second leading cause of cancer death in China, and is one of the most serious threats to people's health. Early diagnosis and treatment can significantly improve the prognosis of PLC. Abnormal glycosylation is reported to be closely related to the genesis and development of malignant tumors. With the advent of modern proteomic and glycomic methodologies, several alterations in fucosylation, sialylation, and glycan branching have been observed in serum of patients with PLC. Altered glycosylation profiles, glycosyltransferases and glycosylated proteins could be screened and used as potential serum markers for early diagnosis, progression monitoring and prognosis evaluation of PLC.(Chin J Lab Med, 2016, 39: 73-75) Key words: Liver Neoplasms; Glycosylation; Glycosyltransferases; Tumor Markers, Biological; Early Diagnosis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
